ACST - Acasti Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ACST is currently covered by 2 analysts with an average price target of $31.25. This is a potential upside of $27.9 (832.84%) from yesterday's end of day stock price of $3.35.

Acasti Pharma's activity chart (see below) currently has 3 price targets and 6 ratings on display. The stock rating distribution of ACST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 48.33 days.

Highest price target for ACST is $5, Lowest price target is $4, average price target is $31.25.

Most recent stock forecast was given by CONSTANTINE DAVIDES from BENCHMARK on 15-Feb-2023. First documented stock forecast 13-Jan-2020.

Best performing analysts who are covering ACST - Acasti Pharma:

Leland Gershell Mayank Mamtani Constantine Davides

Currently out of the existing stock ratings of ACST, 2 are a BUY (100%).

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-0.28 (-10.07%)

1 years 2 months 3 days ago

1/1 (100%)

$1.86 (290.63%)




1 years 9 months 27 days ago

0/1 (0%)

$22.32 (290.63%)


3 years 7 months 18 days ago

0/1 (0%)

$59.52 (163.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACST (Acasti Pharma) average time for price targets to be met?

On average it took 48.33 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on ACST (Acasti Pharma) with a proven track record?


Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?


Which analyst has the most public recommendations on ACST (Acasti Pharma)?

Leland Gershell works at OPPENHEIMER and has 23 price targets and 12 ratings on ACST

Which analyst is the currently most bullish on ACST (Acasti Pharma)?

Mayank Mamtani with highest potential upside - $0

Which analyst is the currently most reserved on ACST (Acasti Pharma)?

Constantine Davides with lowest potential downside - -$0.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?